Solara Active Pharma Sciences appointed Mr Rajender Juvvadi Rao as Managing Director & Chief Executive Officer (MD & CEO) of the Company. Mr. Rajender Rao is currently the Executive Vice Chairman of the Company has been given the responsibility of MD & CEO.
Mr Rajender Juvvadi Rao has done Mechanical Engineering from Osmania University 1988 & PGDIT from Indian Institute of Foreign Trade (liFT) New Delhi 1992.
Mr Rajender Juvvadi Rao commenced Professional career with Reliance Industries Ltd handling exports of Liquids.
Mr Rajender Juvvadi Rao Joined as the first Employee for Nicholas Piramal in 1996. Later co-founded “RA Chempharma” in 2003 and acquired a loss making company. Transformed the loss making acquisition into a viable profit making unit within a span of two years. Envisioned an integrated vertical model as the essence of success and value creation in pharma -a move that initiated a series of acquisitions and amalgamations. This resulted in creation of an API, FDF and a Bio analytical and bio equivalence study facility completing the vertical integration. Focus on organic growth thereafter led to business consolidation and building of teams of integrity, competencies and abilities. The three divisions put together had around 1000 employees. The product identification and selection, developing niche products under API and FDF and bringing in vertical integration into certain products have been the key strengths that Raj has brought to fore in driving “RA Chempharma” into the entity that it had evolved into.
“RA Chempharma” faced multiple regulatory audits from USFDA, UK MHRA, European authorities across all the three divisions and the teams had reached a state of preparedness that enables practicing highest standards of manufacturing and record keeping that enables Audit readiness on an ongoing basis. A widely dispersed shareholding led to a decision to sell majority stake in “RA Chempharma” to Microlabs, Bengaluru towards end of 2016 that enabled him to venture into and create a new entity Aurore Life Sciences Pvt Ltd- a pure play API Player.
Within Four years of its journey, Aurore has reached Revenues of about INR 550 crores with a healthy bottom line
and has created manufacturing capacities of 800 KL. Aurore is poised for an aggressive growth with the backing of a very competitive team including a strong R&D team.
He is also a Director on the Board of the following Companies: –
- Aurore Life Sciences Private Limited
- Aurore Pharmaceuticals Private Limited
- R. A. Labels and Stickers Private Limited